28 related articles for article (PubMed ID: 9890179)
21. Expression of the c-myc proto-oncogene in prostatic tissue.
Matusik RJ; Fleming WH; Hamel A; Westenbrink TG; Hrabarchuk B; MacDonald R; Ramsey E; Gartner JG; Pettigrew NM; Johnston B
Prog Clin Biol Res; 1987; 239():91-112. PubMed ID: 2443918
[No Abstract] [Full Text] [Related]
22. Alterations of cell cycle-regulatory genes in prostate cancer.
Fernández PL; Hernández L; Farré X; Campo E; Cardesa A
Pathobiology; 2002; 70(1):1-10. PubMed ID: 12415186
[TBL] [Abstract][Full Text] [Related]
23. The puzzle of prostatic carcinoma.
Koss LG
Mayo Clin Proc; 1988 Feb; 63(2):193-7. PubMed ID: 3276977
[No Abstract] [Full Text] [Related]
24. Re: Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
Rubin MA
J Natl Cancer Inst; 1999 Jan; 91(1):91. PubMed ID: 9890179
[No Abstract] [Full Text] [Related]
25. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in chronic lymphocytic leukaemia.
Binet JL
Haematologica; 1999 Jun; 84 Suppl EHA-4():96-7. PubMed ID: 10907482
[No Abstract] [Full Text] [Related]
27. Stem cell features of benign and malignant prostate epithelial cells.
De Marzo AM; Nelson WG; Meeker AK; Coffey DS
J Urol; 1998 Dec; 160(6 Pt 2):2381-92. PubMed ID: 9817389
[TBL] [Abstract][Full Text] [Related]
28. Current and proposed biologic markers in prostate cancer: 1994.
Bostwick DG; Qian J
J Cell Biochem Suppl; 1994; 19():197-201. PubMed ID: 7823592
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
